Suppr超能文献

老年和超高龄晚期卵巢癌患者:年龄会影响手术管理吗?

Elderly and very elderly advanced ovarian cancer patients: does the age influence the surgical management?

机构信息

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Catholic University of the Sacred Heart, L.go A. Gemelli 8, 00168 Rome, Italy.

出版信息

Eur J Surg Oncol. 2012 Dec;38(12):1204-10. doi: 10.1016/j.ejso.2012.08.003. Epub 2012 Aug 28.

Abstract

BACKGROUND

To examine the surgical treatment and clinical outcome of elderly and very elderly advanced epithelial ovarian cancer patients.

METHODS

We retrospectively analyzed FIGO stage IIIC-IV ovarian cancer patients, divided in elderly (Group A, >65 and <75 years) and very elderly patients (Group B, ≥ 75 years) treated by primary debulking surgery (PDS) or by interval debulking surgery (IDS) at the Catholic University at Rome and Campobasso, Italy.

RESULTS

164 patients were included: 123 (Group A) and 41 (Group B). Complete cytoreduction was achieved in 60 patients (60.6%) in Group A and in 20 patients (62.5%) in Group B (p = 0.75). In the remaining cases, optimal cytoreduction was performed (39 cases (39.4%) in Group A and 12 (37.5%) in Group B; p = 0.75). In Group A complete/optimal debulking was achieved in 53 patients (53.5%) at PDS and in 46 patients (46.5%) at IDS (p = 0.55). In the Group B a higher rate of patients was debulked at IDS with respect to PDS (10 (31.3%) vs. 22 patients (68.7%); p = 0.02). In Group A patients debulked at PDS showed better DFS (p = 0.007) and OS (p = 0.003) with respect to patients submitted to successful IDS, whereas in group B we did not observed any survival difference according to time of cytoreduction.

CONCLUSIONS

Our data suggest that elderly and very elderly patients may tolerate radical and ultra-radical surgery. These patients should be managed in a gynecologic oncology unit, with prudent but complete approach.

摘要

背景

探讨老年和超高龄晚期上皮性卵巢癌患者的手术治疗及临床结局。

方法

我们回顾性分析了国际妇产科联盟(FIGO)分期为 III C-IV 期卵巢癌患者,根据年龄分为老年组(A 组,>65 岁且<75 岁)和超高龄组(B 组,≥75 岁)。A 组接受了初次肿瘤细胞减灭术(PDS),B 组接受了间隔肿瘤细胞减灭术(IDS)。

结果

共纳入 164 例患者,A 组 123 例,B 组 41 例。A 组 60 例(60.6%)和 B 组 20 例(62.5%)达到完全肿瘤细胞减灭(p = 0.75)。其余病例行满意肿瘤细胞减灭术(A 组 39 例,39.4%;B 组 12 例,37.5%;p = 0.75)。A 组中,PDS 组 53 例(53.5%)和 IDS 组 46 例(46.5%)达到完全/满意肿瘤细胞减灭(p = 0.55)。B 组中,IDS 组肿瘤细胞减灭率高于 PDS 组(10 例,31.3%比 22 例,68.7%;p = 0.02)。A 组中,PDS 组患者的无进展生存(DFS)(p = 0.007)和总生存(OS)(p = 0.003)均优于成功接受 IDS 组的患者,而 B 组中,根据肿瘤细胞减灭时间,DFS 和 OS 未见差异。

结论

我们的数据表明,老年和超高龄患者可耐受根治性和超根治性手术。这些患者应在妇科肿瘤学单位进行管理,采用谨慎但完整的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验